Skip to main content
Swing Capital

Vaishali Pharma Ltd

NSE: VAISHALIPharma

Incorporated in 1989, Vaishali Pharma Ltd does marketing of pharmaceutical products including active pharmaceutical ingredients[1]

₹7
52W: ₹4.75 — ₹13.6
PE 0 · Book ₹5.16 · +36% vs book
Market Cap₹91.4 Cr
Stock P/E—Price to Earnings
ROCE4.93%Return on Capital
ROE1.52%Return on Equity
Div. Yield0%Face Value ₹2

Strengths

  • +Debtor days have improved from 221 to 172 days.

Weaknesses

  • −Though the company is reporting repeated profits, it is not paying out dividend
  • −Company has low interest coverage ratio.
  • −The company has delivered a poor sales growth of 10.5% over past five years.
  • −Promoter holding is low: 31.6%
  • −Company has a low return on equity of 6.31% over last 3 years.
  • −Earnings include an other income of Rs.3.57 Cr.
  • −Company has high debtors of 172 days.

Shareholding Pattern

Promoters31.61%
FIIs0%
DIIs0%
Public68.39%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters26.32%26.32%26.32%26.32%26.32%26.32%31.61%▲5.331.61%
FIIs0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%
Public73.68%73.67%▼0.073.68%▲0.073.68%73.68%73.68%68.39%▼5.368.39%

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales12.5727.932.418.0820.7927.9132.2523.7533.4524.65
Expenses9.9224.9539.1915.7318.3726.5538.2922.3832.0623.09
Operating Profit2.652.95-6.792.352.421.36-6.041.371.391.56
OPM %21.08%10.57%-20.96%13%11.64%4.87%-18.73%5.77%4.16%6.33%
Net Profit1.72.11-4.681.71.971.44-4.291.281.181.3
EPS ₹0.160.2-0.440.160.180.13-0.40.120.090.1

AI Insights

Revenue Trend

TTM revenue at ₹114Cr, up 15.2% YoY. OPM at -2%.

Debt Position

Borrowings at ₹16Cr. Debt-to-equity ratio: 0.39x. Healthy balance sheet.

Institutional Flow

DIIs: 0% (+0.00pp change). FIIs: 0% (+0.00pp change). Promoters hold 31.61%.

Margin & Efficiency

ROCE declining from 19% (Mar 2014) to 5% (Mar 2025). Working capital days: 231.

Recent Announcements